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Ear surgeryAbstract Background: Monitored anesthesia care (MAC) is the practice of administrating local
anesthesia in combination with IV sedatives, anxiolytics and/or analgesic drugs during certain sur-
gical procedures. Most of ear surgeries can be done under monitored anesthesia care.
Methodology: This is a randomized, double blind, prospective study and 100 patients undergoing
ear surgery under MAC were divided into two groups of 50 patients each. The patients in group (D)
received dexmedetomidine 1 lg/kg IV over 10 min followed by 0.7 lg/kg/h + nalbuphine 100 lg/kg
IV and in group (M) received midazolam 20 lg/kg IV followed by 20 lg/kg/h + nalbuphine 100 lg/
kg over 10 min. Assessment of sedation by Ramsay sedation score, requirement of intraoperative
rescue sedation, intraoperative VAS, intraoperative rescue analgesia, intraoperative hemodynamics,
intraoperative bleeding, intraoperative complications, postoperative visual analogue score and post-
operative rescue analgesia requirement, time to achieve full recovery and satisfaction scores of
patients and surgeon were recorded.
Results: Group (D) showedmore sedation byRamsay sedation score than themidazolam (M) group.
Fifty percent in group (M) needed more rescue sedation than 26% in group (D) (p< 0.05). Intraop-
erative VAS was signiﬁcantly higher in group (M) than in group (D) that led to the use of more rescue
analgesia in 60% of group (M). Intraoperative heart rate and mean blood pressure were signiﬁcantly
lower in group (D) than in group (M) (p< 0.05). There was no statistical difference between the two
groups as regards respiratory rate or SpO2. Intraoperative bleeding is less signiﬁcantly less in group
8 M.H. Mohamed, K.Y.K. Hakim(D). Intraoperative hypotensionwas signiﬁcantly higher in group (D) (30%) than in group (M) (20%).
Bradycardiawas insigniﬁcantly higher in group (D).As regards postoperativeVAS, group (D)was sig-
niﬁcantly lower than group (M). This led to the use of more rescue analgesia in 94% of group (M).
There was no statistically signiﬁcant difference between the two groups as regards recovery time.
Patient’s satisfaction was signiﬁcantly higher in group (D) (80%) compared with group (M) (60%)
(p>0.05). The same as regards doctor’s satisfaction where satisfaction was signiﬁcantly higher in
group (D) (76%) than in group (M) (54%).
Conclusion: We concluded that the combination of dexmedetomidine/nalbuphine is a better alterna-
tive to midazolam/nalbuphine in MAC since it provides analgesia, amnesia and sedation with better
intraoperative and postoperative patient satisfaction with better surgical ﬁeld exposure.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.1. Introduction
According to the American Society of Anesthesiologists
(ASA), a monitored anesthesia care (MAC) is a planned surgi-
cal procedure during which surgery is performed under local
anesthesia together with sedation and analgesia [1]. The 3
essential elements and purposes of a conscious sedation during
a MAC are as follows: safe sedation, control of the patient
anxiety and analgesia [2]. Most of ear surgeries can be done
under monitored anesthesia care. It is essential for such deli-
cate procedures to have a bloodless surgical ﬁeld which can
be provided by the addition of vasoconstrictor agent (usually
epinephrine) to the local anesthetic inﬁltration and avoiding
pain and anxiety [3].
Drugs that can be used during monitored anesthesia care
should be chosen according to the type and time of surgical pro-
cedure, patient’s medical and psychological conditions and
experience of the anesthetic team [4]. Many drugs can be used
for sedation during surgery under local anesthesia with moni-
tored anesthesia care including opioids, benzodiazepines and
propofol [5]. However, propofol may cause respiratory embar-
rassment [6]. Benzodiazepines may result in confusion and sub-
sequent agitation, particularly in old age [7] and opioids are
associatedwith increased risk of respiratory depression and oxy-
gen desaturation [8]. Using combination of two agents can pro-
vide better patient control and allows the use of smaller doses of
each single agent avoiding its undesirable effects.
Midazolam is a benzodiazepine which has sedative and
anxiolytic activities, provides anterograde amnesia, and has
anticonvulsant properties [9].
Alpha-2 adrenoreceptors agonists i.e. clonidine and dex-
medetomidine are increasingly used for their sedative, analge-
sic, sympatholytic and cardiovascular stabilizing effects [10].
Nalbuphine is an agonist–antagonist opioid that is structur-
ally related to oxymorphone and naloxone. Autoradiography
studies indicate that nalbuphine binds to l receptors as well
as to e^ and €a receptors. Nalbuphine acts as an antagonist at
the l receptor and an agonist at the e^ receptor. Activation of
supraspinal and spinal l receptors results in limited analgesia,
respiratory depression, and sedation [11].
2. Patients and methods
The study was conducted in Ain Shams University hospitals at
the ENT surgical department. After institutional Ethics Com-
mittee approval, informed written consent was taken from
each patient included. This study was designed as a random-
ized, double blind clinical trial.Patients who were scheduled for elective ear surgeries
under local anesthesia like tympanoplasty, myringoplasty or
stapedectomies were included in this study. Exclusion criteria
were hypertension, renal impairment, advanced liver disease,
history of alcohol or drug abuse, or allergy to any of the study
medications. Using a computer-generated program, 100 pa-
tients were randomly divided into two groups of 50 patients
each to receive either dexmedetomidine/nalbuphine (group
(D)) or midazolam/nalbuphine (group (M)) for sedation and
analgesia during surgery. To follow the double blind nature
of the study, drugs were prepared by an independent anesthe-
sia technician and diluted to a ﬁxed volume for every single
drug used. The anesthesiologist who attended the surgery
and recorded the data was also blind to both groups assigned.
Baseline heart rate (HR), mean arterial pressure (MAP),
respiratory rate (RR), peripheral oxygen saturation (SpO2)
values were obtained using standard monitors. Intravenous
cannula 22 gauge was inserted. Group (D) patients received
dexmedetomidine 1 lg/kg IV over 10 min followed by 0.7 lg/
kg/h + nalbuphine 100 lg/kg IV and group (M) patients re-
ceived midazolam 20 lg/kg IV over 10 min followed by
20 lg/kg/h + nalbuphine 100 lg/kg. Local anesthetic inﬁltra-
tion was given by the operating surgeon, who was unaware
of the group allocation, using lidocaine 1% with adrenaline
1:200,000. Paracetamol infusion 1gm was given to all patients.
After that, level of sedation was assessed using Ramsay
Sedation Score (RSS). The desired sedation level was deﬁned
as RSSP 3. If RSS was less than 3, rescue sedation with pro-
pofol 100–200 lg/kg/h IV was given. Then surgeon proceeded
to perform the surgery under local anesthesia. Intraoperative
visual analogue scale (VAS) was measured. Whenever patient
complained of pain during the surgery, the surgeon used an
additional dose of local anesthetic.
Heart rate (HR), mean arterial pressure (MAP), respiratory
rate(RR), and peripheral oxygen saturation (SpO2) were re-
corded every 10 min till 60 min. Intraoperative bleeding was
assessed by bleeding scale (0–4), acceptable bleeding score
being 0–2, if bleeding score >2 propofol was given.
All adverse events like bradycardia (HR< 55 beats/min),
hypotension (MAP< 50 mmHg sustained for >10 min), respi-
ratory depression (respiratory rate < 10 bpm), oxygen desatu-
ration (SpO2 < 90%), nausea or vomiting were recorded.
After completion of the surgery patients were transferred to
the recovery room where the following were done:
 Assessment of postoperative pain using Visual Analogue
Scale (0–10 cm); if VAS was >3, analgesia was provided
with intravenous tramadol 0.5–1 mg/kg.
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mines, till score of 10 was achieved. Time to achieve Aldrete
score of 10 was recorded, which was the time to shift the
patient to the ward.
 Assessment of patient’s satisfaction was done by asking the
patient to answer the question, ‘‘How would you rate your
experience during surgery?’’ using a 7-point Likert verbal
rating scale. This assessment of patient’s satisfaction was
performed just before shifting to ward to minimize the
effects of sedation on patient’s judgment.
 Surgeons were also asked to rate their satisfaction with
operative conditions, using the 7-point Likert verbal rating
scale at the end of surgery, acceptable satisfaction score of
both the patient and surgeon being 5–7.
2.1. Various scores used in the study
2.1.1. Sedation scale (Ramsay Sedation Scale) is as follows:
1. Anxious, agitated or restless.
2. Cooperative, oriented and tranquil.
3. Responds to command.
4. Asleep but has a brisk response to light glabellar tap or
loud auditory stimulus.
5. Asleep has a sluggish response to a light glabellar tap
or loud auditory stimulus.
6. Asleep no response.2.1.2. Intraoperative bleeding scale0-No bleeding.
1-Slight bleeding; no suctioning of blood required.
2-Slight bleeding; occasional suctioning required. Surgi-
cal ﬁeld not threatened.
3-Slight bleeding; frequent suctioning required. Bleeding
threatened surgical ﬁeld a few seconds after suction was
removed.
4-Moderate bleeding; frequent suctioning required.
Bleeding threatened surgical ﬁeld directly after suction
was removed.
2.1.3. Likert scale1 2 3 4 5 6 7
Extremely dissatisﬁed Dissatisﬁed Somewhat dissatisﬁed Undecided Somewhat satisﬁed Satisﬁed Extremely satisﬁed2.1.4. Postanesthesia recovery score (Modiﬁed Aldrete Score)Parameter Score
2 1
Activity Moves all extremities
voluntarily or on command
Moves two
or on comm
Respiration Breathes deeply and coughs freely Dyspnea, sh
Circulation BP ± 20 mm of preanesthetic level Bp ± 20–50
Consciousness Fully awake Arousable o
Oxygen saturation SpO2 >92% on room air Supplement
to maintain
Total score = 10; A score of P9 required for discharge2.1.5. Visual Analogue Scale VAS (0–10cm)
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th O2 supData analysis was made by using SPSS 18.0 for Windows. It
was estimated that a sample size of 50 patients per group would
achieve a power of 90% with type I error 0.05. The test statistic
used was the two-sided unpaired t-test and the type I error was
set at 0.05.Comparisonbetween the twogroups as regardsnumer-
ical variables was made by using Student’s t-test for comparing
means and standard deviation (quantitative data) andChi-square
test for non-numerical variables (qualitative data). Signiﬁcant
results were deﬁned when the p-value was less than 0.05.
3. Results
The demographic data of the two study groups are summa-
rized in Table 1. Statistical analysis revealed non-signiﬁcant
differences between the two study groups as regards age, sex
distribution, weight and duration of surgery. The surgical pro-
cedure performed in patients was either: myringoplasty, tym-
panoplasty, or stapedectomy. The distribution of these
procedures between the two study groups was found to be
non-signiﬁcantly (p> 0.05) different between the study
groups.
Intraoperative sedation was measured by using Ramsay
sedation score. It revealed that there was statistically signiﬁ-
cant difference between the two studied groups, where the dex-
medetomidine (D) group (4.254 ± 1.054) showed more
sedation than the midazolam (M) group (3.548 ± 1.577). This
result led to statistically signiﬁcant difference between the two
groups as regards the use of rescue sedation where group (M)
25 patients (50%) while group (D) 13 (26%) patients needed
propofol infusion (p< 0.05). Total dose of propofol needed
as rescue sedation was statistically signiﬁcant less in group
(D) than in group (M). Table 2.
Intraoperative pain was measured by using visual analogue
scale (VAS). It showed that there was statistically signiﬁcantdifference between the two studied groups, where the VAS
was less in group (D) (3.87 ± 1.112) than in group (M)
(5.87 ± 1.874). This result led to statistically signiﬁcanties
etic level
plementation
Table 1 Demographic data of the two study groups.
D (n= 50) M (n= 50) Test
t P-value
Age (year) (Mean ± SD) 34.14 ± 7.54 32.5 ± 6.87 1.13 0.2584
Weight (kg) (Mean ± SD) 79.564 ± 15.156 75.478 ± 17.654 1.242 0.217
Duration of surgery (min) (Mean ± SD) 55.7 ± 10.7465 53.457 ± 9.787 1.091 0.277
Sex N (%)
Male 30(60%) 28(56%) 1.963 0.1612
Female 20(40%) 22(44%)
Type of surgery N (%)
Myringoplasty 12(24%) 15(30%) 0.477 0.7880
Tympanoplasty 20(40%) 19(38%)
Stapedectomy 18(36%) 16(32%)
Table 2 Intraoperative variables.
Intraoperative D (n= 50) M (n= 50) T-test
t P-value
Sedation score 4.254 ± 1.054 2.75 ± 0.95 7.49 <0.001\
Intraoperative rescue sedation (if RSS = 1, 2) n(%) 13(26%) 25(50%) 5.136 0.023\
Propofol dose (mg) 140.52 ± 23.12 255.14 ± 30.24 21.292 <0.001\
VAS 3.87 ± 1.112 5.87 ± 1.874 6.494 <0.001\
Intraoperative rescue analgesic (if VAS > 3) n(%) 17(34%) 30(60%) 5.781 0.016\
Intraoperative bleeding (0–2) 39(78%) 29(58%) 3.722 0.05\
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analgesic drug if VAS > 3 where 30 patients in group (M)
(60%) and 17 patients in group (D) (34%) needed paracetamol
infusion (p< 0.05). Table 2.
Intraoperative bleeding measured by bleeding scale was sta-
tistically signiﬁcant less in group (D) than in group (M). Bleed-
ing scale (0–2) was 78% in group (D) while in group (M) it was
58% (p< 0.05). Table 2.
Intraoperative hemodynamics (heart rate, mean blood
pressure, respiratory rate, and SpO2) were measured every
10 min for 60 min. Heart rate and mean blood pressure were
statistically signiﬁcant lower in group (D) than in group (M)
after 10 min from the start to the end of the procedure
(p> 0.05). Respiratory rate and, SpO2 were statistically
insigniﬁcant throughout all the procedure (p> 0.05).
Table 3.
As regards intraoperative complications 20% of patients in
group (D) had bradycardia (HR < 55) in comparison with
12% of patients in group (M) showing statistically insigniﬁcant
difference between them (p> 0.05). In mean blood pressure
there was statistically signiﬁcant difference between the two
studied groups where 15 patients (30%) in group (D) had
hypotension (MAP< 50 mmHg) while 5 patients (10%) only
in group (M) had hypotension (p> 0.05). There was no signif-
icant difference between the two groups as regards nausea and
vomiting (p> 0.05). No cases had respiratory rate < 10 per
minute or SpO2 < 90%. Table 4.
Postoperative VAS was measured and there was highly
statistically signiﬁcance between the two groups where group
(D) (4.51 ± 1.77) was less than group (M) (6.54 ± 1.87)
(p< 0.05). This result led to statistically signiﬁcant difference
between the two groups as regards the use of rescue analgesicdrug if VAS > 3 where 47 patients in group (M) (94%) and 32
patients in group (D) (64%) needed tramadol injection
(p< 0.05). Table 5.
There was no statistically signiﬁcant difference between the
two groups as regards the recovery time. Time to achieve score
10 in Aldrete score was (12.54 ± 2.054) in group (D) in com-
parison with (11.879 ± 1.987) in group (M) (p> 0.05).
Table 5.
Patient’s satisfaction was signiﬁcantly higher in group (D)
(80%) compared with group (M) (60%) (p< 0.05). The same
as regards doctor’s satisfaction where satisfaction was signiﬁ-
cantly higher in group (D) (76%) than in group (M) (54%)
(P> 0.05). Table 5.
4. Discussion
One of the most valuable developments in health care delivery
is the shift from inpatient to outpatient surgery and the asso-
ciated day-case anesthesia. The main beneﬁt for this change
is the economic savings afforded by not admitting patients
the night before surgery or keeping them in hospital the night
after surgery. Other advantages of outpatient surgery include
earlier ambulation, better patient convenience, and a lower
risk of nosocomial infection [12]. Essential characteristics for
agents of day-case anesthesia are early discharge and cost
effectiveness [13]. One of the methods of outpatient anesthesia
is Monitored Anesthesia Care (MAC) which is a technique of
combining local anesthesia with parenteral drugs for sedation
and analgesia.
Using single agent for MAC usually does not provide full
control of the patient’s status and almost always requires intra-
operative intervention with rescue medications. So, combining
Table 3 Intraoperative hemodynamics.
D M T-test
Mean SD Mean SD t P-value
Heart rate (bpm) T0 91.15 ±5.654 90.754 ±4.879 0.375 0.709
T1 65.15 ±3.54 76.48 ±4.5 13.990 <0.001\
T2 60.254 ±5.465 70.354 ±5.245 9.428 <0.001\
T3 60.42 ±5.0589 68.4 ±3.875 8.855 <0.001\
T4 59.48 ±2.23 69.79 ±3.87 16.330 <0.001\
T5 61.125 ±3.458 68.787 ±4.254 9.883 <0.001\
Mean arterial pressure (mmHg) T0 85.564 ±5.44 87.564 ±6.185 1.717 0.089
T1 73.56 ±3.5 87.34 ±5.56 14.831 0.000\
T2 70.165 ±5.89 85.3465 ±5.89 12.880 0.000\
T3 70.05 ±4.99 80.654 ±4.4 11.271 0.000\
T4 65.87 6.87 78.54 ±4.546 10.872 0.000\
T5 60.58 ±6.58 75.54 ±3.654 14.055 0.000\
Respiratory rate (pm) T0 18.56 ±1.564 18.46 ±1.09 0.371 0.712
T1 17.65 ±1.335 18.089 ±1.216 1.719 0.089
T2 18.65 ±1.056 18.13 ±1.8 1.762 0.081
T3 17.998 ±1.6 17.556 ±0.8749 1.714 0.090
T4 17.5 ±1.115 17.223 ±0.95 1.337 0.184
T5 17.89 ±1.88 17.654 ±0.784 0.819 0.415
SpO2 (%) T0 97.564 ±1.54 97.105 ±1.0578 1.737 0.086
T1 98.654 ±0.89 98.2547 ±1.21345 1.876 0.064
T2 98.65 ±1.8 98.24 ±0.94651 1.426 0.157
T3 97.65 ±1.246 97.445 ±0.78730. 0.984 0.328
T4 98.675 ±1.687 98.254 ±1.18 1.446 0.151
T5 97.857 ±1.887 98.077 ±0.879 0.747 0.456
Table 4 Intraoperative complications.
D M Total Chi-square
N % N % N % X2 P-value
Bradycardia 10 20.00 6 12.00 16 16.00 0.670 0.413
Hypotension 15 30.00 5 10.00 20 20.00 5.062 0.024\
N&V 4 8.00 3 6.00 7 7.00 0.00 1.000
Table 5 Postoperative variables.
Postoperative D (n= 50) M (n= 50)
VAS 4.51 ± 1.77 6.54 ± 1.87 5.575 < 0.001\
Postoperative rescue analgesic (If VAS > 4) n(%) 32(64%) 47(94%) 11.814 <0.001\
Time to achieve to 10 in Aldrete score 12.54 ± 2.054 11.879 ± 1.987 1.636 0.105
Patients satisfaction (5–7) 40(80%) 30(60%) 3.857 0.049\
Doctors satisfaction (5–7) 38(76%) 27(54%) 4.397 0.036\
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and hence decreasing its own undesired effects and gains the
augmented desirable effects of each.
We compared the efﬁciency and safety of dexmedetomidine/
nalbuphine versus midazolam/nalbuphine as intravenously
administered agents for MAC during surgical ear procedures
conducted under local anesthesia. We found that mean Ramsay
Sedation Score (RSS) was signiﬁcantly more in dexmedetomi-
dine/nalbuphine group (group (D)) than in midazolam/nalbu-
phine group (group (M)). Rescue sedation with propofolinfusion to achieve target sedation level (Ramsay score of 3)
was required by signiﬁcantly higher number of patients in group
(M) (50%) as compared to group (D) (26%).
The sedative effects of midazolam are mediated through
GABAreceptor activation.Midazolamcould reducepainpercep-
tion by reducing the emotional component of pain through its
anxiolytic and amnestic effects as anxiety and pain are intimately
related so that anxiety leads to an exacerbation of pain [14].
Dexmedetomidine has a high ratio of speciﬁcity for the a2
versus the a1 receptor (200: 1 for clonidine and 1600: 1 for dex-
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adrenoceptors, it inhibits the release of norepinephrine and
subsequently decreases sympathetic tone. It also attenuates
the neuroendocrine and hemodynamic responses to anesthesia
and surgery, leading to sedation and analgesia [15]. The high-
est density of a2 receptors has been detected in the locus ceru-
leus, the predominant noradrenergic nucleus in the brain and
an important modulator of vigilance. The sedative effects of
a2 adrenoceptor activation have been attributed to this site
in the CNS, and this allows psychomotor function to be pre-
served while making the patient rest comfortably, so patients
are able to return to their baseline level of consciousness when
stimulated which is beneﬁcial for MAC [10]. Both Clonidine
and dexmedetomidine seem to offer these beneﬁcial properties,
but dexmedetomidine has a shorter half-life, which might be
more suitable for MAC. There are reports that dexmedetomi-
dine alone does not appear to be suitable for sedation in pa-
tients undergoing cataract surgery and midazolam is a better
sedative agent. Although those reports stated that there was
a slightly better subjective patient satisfaction with dexmede-
tomidine, it was found effective for sedation with vascular sur-
geries [14]. Based on this pharmacologic background, our
results may be explained on the fact that dexmedetomidine is
a more effective sedative and analgesic agent with better pres-
ervation of psychomotor function in the give doses by its sym-
pathetic attenuating effect while midazolam has minimal
analgesic effect (emotional component) and its sedative effect.
Nalbuphine is a good analgesic for mild to moderate, but
not severe, postoperative pain. It is only available for paren-
teral use. Onset of action is rapid (5–10 min), and duration
of action is long (3–6 h) because of a long plasma elimination
half-life (5 h). Hepatic metabolism and fecal excretion account
are the main methods of elimination. Nalbuphine (0.6 mg/kg)
produces no or minimal hemodynamic changes in ASA classes
I and II patients [11].
We observed that intraoperative rescue analgesic require-
ment was signiﬁcantly less in group (D) (34%) than in group
(M) (60%), (p< 0.05). Postoperative VAS score was also sig-
niﬁcantly less in group (D) (64%) than in group (M) (94%).
The better analgesic effect of a2 agonists has been demon-
strated in other studies too [16,17].
Intraoperative bleeding was signiﬁcantly less in group (D)
as compared to group (M). Controlled intraoperative hypoten-
sion effectively decreases surgical blood loss and improves sur-
gical ﬁeld exposure which is essential for otology surgeries.
Dexmedetomidine facilitates controlled hypotension by
decreasing the heart rate, systolic, diastolic and mean blood
pressure. Dexmedetomidine was found effective in reducing
bleeding in ENT surgeries [18]. We also observed that mean
heart rate and mean arterial pressure were signiﬁcantly lower
from baseline at various time intervals in group (D) than in
group (M).
Safety is a main concern for any MAC technique. However,
a poorly controlled technique may result in deep sedation or
general anesthesia with all its attendant risks. Therefore using
more than one agent may allow the anesthetist to use fewer
doses decreasing the harmful effects of each and allows aug-
menting the beneﬁcial effects of each drug used.Limitations of our study were as follows: ﬁrstly, inclusion
of a broad variety of Ear surgeries for the study. This needed
a lot of surgeons to do different types of surgeries. Secondly,
some surgeons refused to give patients local anesthesia, so col-
lecting 100 patients in the study was difﬁcult.
In this study we used two agents for performing MAC for
ear surgeries; we found that the combination of dexmedetom-
idine/nalbuphine is superior to midazolam/nalbuphine as re-
gards level of sedation and operative conditions.
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